MyCelx Technologies Corporation Closure of Restricted Stock Line (9635S)
15 March 2023 - 3:50AM
UK Regulatory
TIDMMYX TIDMMYXR
RNS Number : 9635S
MyCelx Technologies Corporation
14 March 2023
14 March 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Closure of Restricted Stock Line
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and clean air technology company, confirms the closure
of its restricted line of stock will take effect at 8.00 a.m. on 22
March 2023.
Application has been made to the London Stock Exchange for the
transfer of an additional 3,539,273 common shares of $0.25 each
("Common Shares") (the "Additional Shares") from the Company's
restricted line of stock with the ticker MYXR (identified under
ISIN USU624551235) (the "Restricted Line") to the Company's
unrestricted line of stock with the ticker MYX (identified under
ISIN US62847T2024) (the "Unrestricted Line").
The Additional Shares are constituted of 3,539,273 Common Shares
which have been transferred upon expiry of the restricted period
under Regulation S of the US Securities Act of 1933.
Trading in the Company's Restricted Line will cease at 8.00 a.m.
on 22 March 2023 and all Common Shares currently trading on the
Restricted Line will from then on continue to trade on the
Unrestricted Line. Certificated holders will also be issued a
replacement share certificate, representing their new holding in
unrestricted shares.
The Company's issued share capital consists of 22,983,023 Common
Shares with no Common Shares held in treasury. Therefore, the total
number of voting rights in the Company is 22,983,023 which may be
used by shareholders as the denominator for the calculations by
which they determine if they are required to notify their interest
in, or a change to their interest in, the Company under the
Financial Conduct Authority's Disclosure Guidance and Transparency
Rules.
From 22 March 2023, all of the 22,983,023 Common Shares will be
admitted to trading on the Unrestricted Line.
For further information, please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity Limited (Nomad and Sole Broker)
Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000
Gordon Hamilton
Celicourt Communications (Financial PR)
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCJIMFTMTIBBTJ
(END) Dow Jones Newswires
March 14, 2023 12:50 ET (16:50 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Apr 2024 to May 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From May 2023 to May 2024